OrbusNeich Medical Group Holdings Limited (OrbusNeich) (/ˌɔːrbəsˈniːʃ/ or-bəs-NEESH) is a global pioneer in the provision of life-changing vascular solutions and offers an extensive portfolio of products that set industry benchmarks in vascular intervention. In 2013, OrbusNeich received CE mark for the world's first and only dual therapy stent, the COMBO Dual Therapy Stent. The COMBO Stent features active endothelial progenitor cell (EPC) capture technology, which promotes the accelerated natural healing of the vessel wall after the implantation of a stent. Several trials including a randomized study dedicated to patients with Acute Coronary Syndrome (ACS) and registries with a sizeable ACS patient subset demonstrated consistently low event rates and short DAPT option of 3 months, if needed. More information...
According to PR-model, orbusneich.com is ranked 2,281,496th in multilingual Wikipedia, in particular this website is ranked 1,253,924th in English Wikipedia.
The website is placed before westindiaregiment.org and after ilyang.co.kr in the BestRef global ranking of the most important sources of Wikipedia.
